Great West Life Assurance CO Adverum Biotechnologies, Inc. Transaction History

Great West Life Assurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $6,730 - $9,283	-3,868 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$10.3 - $21.64 $39,840 - $83,703	3,868 New	3,868 $39,000
Q3 2020 Nov 13, 2020	SELL	$10.3 - $21.64 $39,840 - $83,703	-3,868 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$5.12 - $12.22 $19,804 - $47,266	3,868 New	3,868 $44,000

2.53M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $748M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.